Themis Medicare (NSE:THEMISMED) Margin of Safety % (DCF Earnings Based): N/A (As of Jul. 01, 2026)


NSE:THEMISMED Themis Medicare Ltd NSE:THEMISMED
74 GF Score
Price ₹109.55
GF Value ₹149.53
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Themis Medicare Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Themis Medicare's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

NSE:THEMISMED vs ZTS, UTHR: Margin of Safety % (DCF Earnings Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Themis Medicare's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Themis Medicare Margin of Safety % (DCF Earnings Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Themis Medicare's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Themis Medicare's Margin of Safety % (DCF Earnings Based) falls into.


NSE:THEMISMED
74GF Score
Themis Medicare Ltd NSE:THEMISMED
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Themis Medicare (NSE:THEMISMED) Overvalued in 2026?

Based on GuruFocus' analysis, Themis Medicare stock appears to be undervalued. The current stock price of ₹109.55 is trading 26.7% below its estimated GF Value™ of ₹149.53. GuruFocus considers Themis Medicare to be Modestly Undervalued.

Key valuation signals for NSE:THEMISMED:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: ₹149.53 vs. price of ₹109.55 (26.7% below fair value)
  • GF Score™: 74/100 with 6 warning signs

No single metric tells the full story. See the NSE:THEMISMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Themis Medicare Business Description

Other Exchanges 530199:India
Address Swami Vivekanand Road, 11/12, Udyog Nagar Industrial Estate, Goregaon (West), Mumbai, MH, IND, 400 104
Themis Medicare Ltd is an Indian based company engaged in the manufacturing and marketing of pharmaceutical products. The Company operates only in one business segment which is Pharmaceuticals. Geographically, it derives a majority of revenue from India and also has a presence in the international market. Its product categories include Anti Malarial, CCD products, Nutritional Gummies, and Candy and Other Products such as OD-LM, Dexem, Medzol and Tazowin.
74GF Score

Get the complete analysis for NSE:THEMISMED

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹109.55
Price
₹149.53
GF Value